Natural killer cells are likely to play an important role in the host
defenses because they kill virally infected or tumor cells but spare n
ormal self-cells. The molecular mechanism that explains why NK cells d
o not kill indiscriminately has recently been elucidated. It is due to
several specialized receptors that recognize major histocompatibility
complex (MHC) class I molecules expressed on normal cells. The lack o
f expression of one or more class I alleles leads to NK-mediated targe
t cell lysis. During NK cell development, the class I-specific recepto
rs have adapted to self-class I molecules on which they recognize epit
opes shared by groups of class I alleles. As such, they may fail to re
cognize either self-molecules that bound unusual peptides or allogenei
c class I molecules unrelated to self-alleles. Different types of rece
ptors specific for groups of HLA-C or HLA-B alleles have been identifi
ed. While in most instances, they function as inhibiting receptors, an
activating form of the HLA-C-specific receptors has been identified i
n some donors. Molecular cloning of HLA-C- and HLA-B-specific receptor
s has revealed new members of the immunoglobulin superfamily with two
or three Ig-like domains, respectively, in their extracellular portion
. While the inhibiting form is characterized by a long cytoplasmic tai
l associated with a nonpolar transmembrane portion, the activating one
has a short tail associated with a Lys-containing transmembrane porti
on. Thus, these human NK receptors are different from the murine Ly49
that is a type II transmembrane protein characterized by a C type lect
in domain. A subset of cytolytic T lymphocytes expresses NK-type class
I-specific receptors. These receptors exert an inhibiting activity on
T cell receptor-mediated functions and offer a valuable model to anal
yze the regulatory mechanisms involved in receptor-mediated cell activ
ation and inactivation.